|
CA2543296A1
|
|
Reconstitutable microsphere compositions useful as ultrasonic contrast agents
|
|
CN1893877A
|
|
Reconstitutable microsphere compositions useful as ultrasonic contrast agents
|
|
EP1673108A2
|
|
Methods and compositions for ultrasound imaging of apoptosis
|
|
EP1608340A2
|
|
A method of preparing gas-filled polymer matrix microparticles useful for delivering drug
|
|
AU2003237820A1
|
|
Microparticles having a matrix interior useful for ultrasound triggered delivery of drugs into the bloodstream
|
|
US6919068B2
|
|
Method of preparing gas-filled polymer matrix microparticles useful for echographic imaging
|
|
US6896659B2
|
|
Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
|
|
WO0112069A1
|
|
Hollow microspheres with controlled fragility for medical use
|
|
EP1202671A1
|
|
Microparticles useful as ultrasonic contrast agents and for lymphatic system
|
|
EP1109531A1
|
|
Local delivery of medications to the heart
|
|
AU5247599A
|
|
A novel excipient for the lyophilization of aqueous suspensions of microparticles
|
|
US2001008636A1
|
|
Microparticulate surgical adhesive
|
|
US6224554B1
|
|
Method to measure ambient fluid pressure
|
|
WO9939697A1
|
|
Method for ultrasound triggered drug delivery
|
|
AU9313298A
|
|
Injectable tissue reconstruction material
|
|
EP0979071A1
|
|
Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
|
|
AU6876498A
|
|
Intravesical drug delivery system
|
|
US6352683B1
|
|
Apparatus and method for the local delivery of drugs
|
|
EP0626822A1
|
|
System for examination of tissue perfusion with ultrasound contrast agent
|
